FDA grants accelerated approval for ADUHELM as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease Read more
Ascletis Received China IND Approval of Its FXR Agonist ASC42 for Chronic Hepatitis B Indication Read more
Dermavant Submits New Drug Application (NDA) to FDA for Tapinarof Cream for the Treatment of Adults with Plaque Psoriasis Read more
3 Exclusive Speaker Interviews Released ahead of Microbiology West Coast Virtual Conference in 2 weeks Read more